Beta-Blocker Influences on Inflammatory and Neural Responses to Stress

Clinical trial NCT06263452 · RECRUITING

Trial details

NCT number: NCT06263452
Sponsor: University of North Carolina, Chapel Hill
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cardiovascular Disease

Start date: 2024-05-01
Primary completion: 2026-05-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.